US2009162397A1PendingUtilityA1

Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins

54
Assignee: PFIZERPriority: Dec 21, 2007Filed: Dec 15, 2008Published: Jun 25, 2009
Est. expiryDec 21, 2027(~1.4 yrs left)· nominal 20-yr term from priority
A61P 31/00A61P 37/04A61P 31/12A61P 31/04A61P 43/00A61P 1/12A61K 9/107A61K 47/24A61K 2039/55505C07K 14/005A61K 2039/70A61K 38/00A61K 2039/552A61K 2039/521A61K 2039/55566A61K 39/12A61K 39/39A61K 39/0225A61K 39/295
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Heat treated bacterins, a method of producing heat treated bacterins, and porcine emulsion vaccines prepared from such heat treated bacterins are disclosed.

Claims

exact text as granted — not AI-modified
1 . A vaccine comprising an emulsion, a heat treated bacterin comprising a suspension of killed bacteria, wherein the killed bacteria are of the species  Leptospira Bratislava  and 1 to 13 porcine disease causing viruses selected from the group consisting of Porcine Adenovirus, Porcine Circovirus, Porcine herpes viruses, Pseudorabies virus, Classical swine fever virus, Porcine epidemic diarrhea virus, Porcine hemaglutinating encephalomyelitis virus, Porcine parvovirus, Porcine Respiratory Corona virus, Porcine Reproductive and Respiratory Virus, Swine Influenza, Transmissible gastroenteritis virus, and Vesicular stomatitis virus. 
   
   
       2 . A vaccine according to  claim 1  further comprising a lecithin preparation, and alum based adjuvant. 
   
   
       3 . A vaccine according to  claim 2  further comprising a lecithin in oil preparation. 
   
   
       4 . A vaccine according to  claim 1  further comprising heat treated bacterins comprising a suspension of killed bacteria, wherein the killed bacteria are one to six bacteria species selected from the group consisting of  Leptospira canicola, Leptospira icterohaemorrhagiae, Leptospira  grippotyphosa,  Leptospira hardjo, Leptospira Pomona , and  Erysipelothrix rhusiopathieae.    
   
   
       5 . A vaccine according to  claim 4  further comprising a lecithin preparation, and alum based adjuvant. 
   
   
       6 . A vaccine according to  claim 5  further comprising a lecithin in oil preparation.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.